Two Sigma Investments
RPRX icon

Two Sigma Investments’s Royalty Pharma RPRX Stock Holding History

Two Sigma Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,300
Closed -$291K – 4070
2021
Q4 		$291K Buy
+7,300
New +$284K ﹤0.01% 3667

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Investments's RPRX Position: Q1 2026 in Review

Two Sigma Investments increased its Royalty Pharma (RPRX) stake by 231% in Q1 2026, buying an estimated $68.8M and bringing the position to 2,251,525 shares worth $108M. The position accounts for 0.09% of the portfolio, ranked #262.

Two Sigma Investments first reported a position in RPRX in Q4 2021 and has held it in 18 quarters since. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Two Sigma Investments held 2,251,525 shares of Royalty Pharma worth $108M as of Q1 2026.
  • Two Sigma Investments bought 1,570,277 Royalty Pharma shares in Q1 2026, an estimated $68.8M.
  • Royalty Pharma made up 0.09% of Two Sigma Investments's portfolio in Q1 2026, its #262 holding.
  • Two Sigma Investments first reported a position in Royalty Pharma in Q4 2021 and has held it in 18 quarters since.
  • 590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.